Path Outline
Progress0%
1Exam Surface Mapping From a Syllabus or Fallback Blueprint2A Minimal Signal-Flow Grammar for Mechanistic Tracing3Perturbation-to-Readout Prediction With Directional Logic4Readout Vocabulary and the Activation-vs-Abundance Trap5Conceptual Figure Sprints: Claims, Controls, and Permissible Conclusions
6Two Receptor Classes, Two Proximal Chemistries7RTK Autophosphorylation and Docking-Site Logic8GPCR–G Protein Switching: Gs vs Gi and Proximal Predictions9Interaction Modules and Recruitment Decisions at the Membrane10Constitutively Active vs Dominant-Negative: Mutation Logic at the Receptor Layer11Protein Naming and Function Checks With NCBI Gene and UniProt12Receptor-Layer Crosstalk as Shared Nodes and Context Dependence13Phospho vs Total at the Receptor: A Proximal Figure Sprint
14cAMP as a Fast Amplifier: From G Proteins to PKA and Termination15Gs vs Gi Logic: When cAMP Goes Up, Down, or Appears to Invert16PLC Splits PIP2: IP3 for Ca2+ Release and DAG for PKC17Perturbing the Fork: IP3 Receptor Block, Ca2+ Chelation, and PKC Inhibition18Ca2+ and Calmodulin: Turning a Transient Ion Signal Into Enzyme Control19Timing and Readouts: Second Messenger Spikes vs Transcriptional Responses20Exam Traps, Readout Mapping, and a Bridge to Kinase Cascades
21MAPK/ERK Wiring and Phospho-Node Predictions22Ras as a Molecular Switch: Mutations and Signal Lock-In23PI3K/Akt Signaling and PTEN as a Brake24Akt Outputs: Growth and Survival Tendencies Without Full Fate Pathways25JAK/STAT: From Receptor-Associated Kinases to Nuclear STAT Dimers26Crosstalk and Feedback: When PI3K Inhibition Changes ERK
27Pathway Databases as Scaffolds, Not Answers
28Inhibitor and Readout Caveats: Off-Target Effects, Controls, and Timing29HER2/ERBB2 Amplification as Increased RTK Drive Into MAPK and PI3K
30Transcription Factor State as the Bridge From Signaling to Gene Expression31Choosing the Right Measurement Layer for Gene-Expression Claims32miRNA Repression and Protein-First Changes Without Big mRNA Shifts33siRNA Knockdown Logic Versus Genome Editing at the Claim Level34lncRNA as Regulatory Scaffold: What Would Count as Evidence?35Biomolecular Condensates as Spatial Organizers of Transcription36Evidence-First Mini-Synthesis: pERK Versus Total ERK and What Nuclear Output Claims Survive
37The Cell Cycle as a Checkpointed State Machine38DNA Damage Signaling and Checkpoint Arrest Predictions39Oncogene Drive vs Tumor Suppressor Enforcement as an Inference Frame40Growth and Survival Signaling Inputs Into Cell-Cycle Entry41DNA-Content Histograms as Evidence: What Shifts Mean and What They Don’t42Timing and Indirect Effects in Cell-Cycle Experiments43Perturbation Panels: Growth Factor Plus CDK Inhibitor Predictions
44Extrinsic vs Intrinsic Apoptosis: Two Initiation Graphs45Caspase Cascades as Amplifiers: Commitment and Timing46Mitochondrial Commitment and BCL-2 Balance Logic47PI3K/Akt Survival Signaling as an Anti-Apoptotic Bias48Conceptual Flow Readouts for Apoptosis: Percent-Positive vs Intensity49Competing Inputs: Arrest, Repair, or Apoptosis Under Combined Perturbations50Apoptosis Inference Traps: Viability, Pathway Claims, and Direct Interaction
51Rate Laws to Michaelis–Menten Curves: What Vmax and Km Actually Control52Inhibition Type From Plot Shifts: Competitive vs Noncompetitive53Lineweaver–Burk Plots: A Diagnostic Tool With Real Limits54Western Blots as Evidence: Loading, Total Protein, and Phospho Controls55Activation State vs Abundance: The “Phospho Band Up” Trap56Time-Course Blots: Order of Events and Control Lanes57Flow Cytometry Histograms: Percent-Positive, MFI Shifts, and Bimodality58Co-IP Evidence: Complex Association, Controls, and Overreach59FRAP Recovery Curves: Mobility, Turnover, and the Phase-Separation Overclaim60CRISPR Modalities, Epistasis-Style Rescue Logic, and Mixed Data Synthesis
Hide outline
  1. Home/
  2. Paths/
  3. Mechanistic Cell and Molecular Biology for Exam Performance: Signaling to Transcription, Cell Fate, /
  4. Pathway Databases as Scaffolds, Not Answers